mesalamine has been researched along with Beryllium Disease in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Beryllium Disease: Disease resulting from exposure to beryllium. Entry into the body is not limited to the inhalation route.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Day, BJ | 2 |
Huang, J | 1 |
Barkes, BQ | 1 |
Gillespie, M | 1 |
Li, L | 1 |
Maier, LA | 2 |
Dobis, DR | 1 |
Sawyer, RT | 1 |
Gillespie, MM | 1 |
Newman, LS | 1 |
1 trial available for mesalamine and Beryllium Disease
Article | Year |
---|---|
5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Berylliosis; Bronchoalveolar Lavage Fluid; Cell Proli | 2018 |
1 other study available for mesalamine and Beryllium Disease
Article | Year |
---|---|
Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production.
Topics: Adult; Antigen-Presenting Cells; Berylliosis; Beryllium; Bronchoalveolar Lavage Fluid; Cell Prolifer | 2010 |